2018
DOI: 10.1016/j.actbio.2018.03.055
|View full text |Cite
|
Sign up to set email alerts
|

Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
53
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 72 publications
(53 citation statements)
references
References 40 publications
0
53
0
Order By: Relevance
“…Until now, large animals with similar anatomy, size and physiology to humans but lacking the ability to generate kidney organs have not been available. Previous studies have shown that CRISPR/Cas9 can be successfully used to generate target mutations in pigs . Here, we efficiently disrupted the SIX1 and SIX4 genes in pigs by altering the protein coding sequence, and we demonstrated that both SIX1 and SIX4 gene knockout in pig foetuses result in disruption of their nephrogenesis phenotype, thereby providing an empty organ niche for the potential generation of human kidneys in pigs.…”
Section: Discussionmentioning
confidence: 81%
“…Until now, large animals with similar anatomy, size and physiology to humans but lacking the ability to generate kidney organs have not been available. Previous studies have shown that CRISPR/Cas9 can be successfully used to generate target mutations in pigs . Here, we efficiently disrupted the SIX1 and SIX4 genes in pigs by altering the protein coding sequence, and we demonstrated that both SIX1 and SIX4 gene knockout in pig foetuses result in disruption of their nephrogenesis phenotype, thereby providing an empty organ niche for the potential generation of human kidneys in pigs.…”
Section: Discussionmentioning
confidence: 81%
“…Besides the dietary exposure to Neu5Gc, humans can also encounter Neu5Gc that is expressed on exogenous glycosylated biotherapeutics, 106,[134][135][136] biodevices, or xenografts, 104,[137][138][139][140][141][142] that are given to human patients. In this case, circulating anti-Neu5Gc antibodies could reduce efficacy of therapy, [134][135][136] elicit an increased and diversified anti-Neu5Gc response that can remain long-lasting, 143,144 or possibly mediate xenograft failure or rejection.…”
Section: Con S Equen Ce S Of Neu5g C and Anti -Neu5g C Antibod Ie Smentioning
confidence: 99%
“…These results suggest that the deletion of Neu5Gc epitope in pigs is crucial for increasing xenograft survival time. In vitro evidence has also suggested that inactivation of the B4GalNT2 gene reduce human antibody binding (34,128). These data indicate that TKO pig organs have proven to be a major advancement compared with GTKO and DKO xenografts following transplantation into human.…”
Section: Deleting Xenoreactive Antigensmentioning
confidence: 97%